Clinical Trial

Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit

Study acronym: HPB
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 21, 2020 (before its estimated January 2024 completion). Its status may not reflect the trial's current state.
Summary
The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.
Trial Details
NCT Number NCT04556019
Lead Sponsor Fundacion Miguel Servet
Conditions Pancreas Disease, Liver Diseases, Surgical Procedure, Unspecified, Bile Duct Diseases
Enrollment 1,000 participants
Start Date 2019-01-03
Primary Completion 2024-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2020-09-21